500 related articles for article (PubMed ID: 33123144)
1. SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment.
Khalaf K; Papp N; Chou JT; Hana D; Mackiewicz A; Kaczmarek M
Front Immunol; 2020; 11():570927. PubMed ID: 33123144
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
Hosoki K; Chakraborty A; Sur S
J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
[TBL] [Abstract][Full Text] [Related]
3. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
Li H; Liu Z; Ge J
J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516
[TBL] [Abstract][Full Text] [Related]
4. COVID-2019: update on epidemiology, disease spread and management.
Sahu KK; Mishra AK; Lal A
Monaldi Arch Chest Dis; 2020 Apr; 90(1):. PubMed ID: 32297723
[TBL] [Abstract][Full Text] [Related]
5. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
Giovane RA; Rezai S; Cleland E; Henderson CE
Rev Med Virol; 2020 Sep; 30(5):e2136. PubMed ID: 32644275
[TBL] [Abstract][Full Text] [Related]
6. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
Gupta SP
Curr Top Med Chem; 2020; 20(26):2362-2378. PubMed ID: 32962613
[TBL] [Abstract][Full Text] [Related]
7. Advances in SARS-CoV-2: a systematic review.
Bai YX; Xu YH; Wang X; Sun C; Guo Y; Qiu S; Ma KW
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9208-9215. PubMed ID: 32965016
[TBL] [Abstract][Full Text] [Related]
8. A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2).
Lee JH; Choi M; Jung Y; Lee SK; Lee CS; Kim J; Kim J; Kim NH; Kim BT; Kim HG
Biosens Bioelectron; 2021 Jan; 171():112715. PubMed ID: 33099241
[TBL] [Abstract][Full Text] [Related]
9. Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Nov; 383(19):e123. PubMed ID: 33211936
[No Abstract] [Full Text] [Related]
10. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence.
Cao YC; Deng QX; Dai SX
Travel Med Infect Dis; 2020; 35():101647. PubMed ID: 32247927
[TBL] [Abstract][Full Text] [Related]
11. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
12. Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity.
Sturley SL; Rajakumar T; Hammond N; Higaki K; Márka Z; Márka S; Munkacsi AB
J Lipid Res; 2020 Jul; 61(7):972-982. PubMed ID: 32457038
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19.
Abd Ellah NH; Gad SF; Muhammad K; E Batiha G; Hetta HF
Nanomedicine (Lond); 2020 Sep; 15(21):2085-2102. PubMed ID: 32723142
[TBL] [Abstract][Full Text] [Related]
14. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Martinez MA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
[TBL] [Abstract][Full Text] [Related]
15. Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19).
Khodadadi E; Maroufi P; Khodadadi E; Esposito I; Ganbarov K; Espsoito S; Yousefi M; Zeinalzadeh E; Kafil HS
Microb Pathog; 2020 Sep; 146():104241. PubMed ID: 32387389
[TBL] [Abstract][Full Text] [Related]
16. Potential therapeutic targets and promising drugs for combating SARS-CoV-2.
Zhou H; Fang Y; Xu T; Ni WJ; Shen AZ; Meng XM
Br J Pharmacol; 2020 Jul; 177(14):3147-3161. PubMed ID: 32368792
[TBL] [Abstract][Full Text] [Related]
17. Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children.
Miao H; Li H; Yao Y; Wu M; Lu C; Wang J; Tian M; Li Y; Luo P; Gu J; Yuan B; Wang S; Zhao X; Gan W; Zhao D
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2211-2223. PubMed ID: 32761481
[TBL] [Abstract][Full Text] [Related]
18. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19.
Fu J; Zhou B; Zhang L; Balaji KS; Wei C; Liu X; Chen H; Peng J; Fu J
Mol Biol Rep; 2020 Jun; 47(6):4383-4392. PubMed ID: 32410141
[TBL] [Abstract][Full Text] [Related]
19. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.
Liya G; Yuguang W; Jian L; Huaiping Y; Xue H; Jianwei H; Jiaju M; Youran L; Chen M; Yiqing J
APMIS; 2020 Jun; 128(6):423-432. PubMed ID: 32363707
[TBL] [Abstract][Full Text] [Related]
20. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview.
Rathore JS; Ghosh C
Pathog Dis; 2020 Aug; 78(6):. PubMed ID: 32840560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
